high fat/high saturated fat diet
Other4 weeks 55% fat/25% saturated fat isocaloric diet
Other names: Diet
NCT Number: NCT00930371
This study is designed to determine if the amount of fat and saturated fat in the diet contributes to the development of a condition called fatty liver disease in the absence of changes in weight.
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Not applicable
University of Washington, Seattle, Washington, United States
A condition called non-alcoholic steatohepatitis is characterized by fat accumulation in the liver and associated inflammation. This condition is strongly associated with obesity, insulin resistance and type 2 diabetes. Diets high in saturated fat result in fatty liver, insulin resistance and liver injury in animal models. Dietary composition may contribute not only to hepatic fat accumulation and insulin resistance but may also promote inflammation leading to chronic liver disease in humans. This study will test the hypothesis that a diet high in fat and saturated fat contributes to liver fat accumulation, insulin resistance and inflammation by comparing the effects of a four-week, weight stable high fat/high saturated fat diet (55% calories from fat/25% saturated fat) with a four-week, weight stable low fat/low saturated fat diet (20% fat/8% saturated fat) in overweight and obese subjects.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
4 weeks 55% fat/25% saturated fat isocaloric diet
Other names: Diet
4 weeks 20% fat/8% saturated fat isocaloric diet
Other names: Diet
Time frame: 4 weeks
Time frame: 4 weeks
Time frame: 4 weeks
Time frame: 4 weeks
University of Washington
Other
Acronym: DietLFAT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05351853
Digestive System Diseases, Fatty Liver
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT04004273
Behavior, Body Weight
Leicester, East Midlands, United Kingdom
View Trial DetailsNCT00323414
Diabetes Mellitus, Diabetes Mellitus, Type 2
Cleveland, Ohio, United States
View Trial DetailsNCT00585299
Digestive System Diseases, Fatty Liver
New Haven, Connecticut, United States
View Trial Details